How to buy Cellect Biotechnology stock (APOP)

Cellect Biotechnology is a biotechnology business based in the US. Cellect Biotechnology shares (APOP) are listed on the NASDAQ and all prices are listed in US Dollars. Cellect Biotechnology employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Cellect Biotechnology stock

Buy Cellect Biotechnology stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Cellect Biotechnology stock price (NASDAQ: APOP)

Use our graph to track the performance of APOP stocks over time.

Cellect Biotechnology shares at a glance

• Key figures

Information last updated 2023-10-25.

52-week range	$0.00 - $0.00
50-day moving average more info button	$17.38
200-day moving average more info button	$7.39
Wall St. target price	$12.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.85

Is it a good time to buy Cellect Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cellect Biotechnology financials

Gross profit TTM	$0
Return on assets TTM	-47.79%
Return on equity TTM	-120.42%
Profit margin	0%
Book value	$0.69
Market Capitalization more info button	$12.9 million

TTM: trailing 12 months

Cellect Biotechnology share dividends

We're not expecting Cellect Biotechnology to pay a dividend over the next 12 months.

Have Cellect Biotechnology's shares ever split?

Cellect Biotechnology's shares were split on a 1:4 basis on 23 September 2021 . So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellect Biotechnology shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Cellect Biotechnology shares which in turn could have impacted Cellect Biotechnology's share price.

Cellect Biotechnology share price volatility

Over the last 12 months, Cellect Biotechnology's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellect Biotechnology's is 1.8767. This would suggest that Cellect Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cellect Biotechnology overview

As of October 28, 2021, Cellect Biotechnology Ltd. was acquired by Quoin Pharmaceuticals, Inc. , in a reverse merger transaction. Cellect Biotechnology Ltd. , a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc.

Frequently asked questions

null
What percentage of Cellect Biotechnology is owned by insiders or institutions?
Currently 3.647% of Cellect Biotechnology shares are held by insiders and 12.24% by institutions. How many people work for Cellect Biotechnology?
Latest data suggests 12 work at Cellect Biotechnology. When does the fiscal year end for Cellect Biotechnology?
Cellect Biotechnology's fiscal year ends in December. Where is Cellect Biotechnology based?
Cellect Biotechnology's address is: 23 Hata?as Street, Kfar Saba, Israel, 44425 What is Cellect Biotechnology's ISIN number?
Cellect Biotechnology's international securities identification number is: US15116C3007 What is Cellect Biotechnology's CUSIP number?
Cellect Biotechnology's Committee on Uniform Securities Identification Procedures number is: 15116C201